Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial. Tang C, Sherry AD, Haymaker C, et al. JAMA Oncol. 2023 Jun 1;9(6):825-834. DOI: 10.1001/jamaoncol.2023.0161. PMID: 37022702; PMCID: PMC10080407. …